Cataract surgery and nonsteroidal antiinflammatory drugs

Richard S. Hoffman, Rosa Braga-Mele, Kendall Donaldson, Geoffrey Emerick, Bonnie Henderson, Malik Kahook, Nick Mamalis, Kevin M. Miller, Tony Realini, Neal H. Shorstein, Richard K. Stiverson, Barbara Wirostko

Research output: Contribution to journalReview articlepeer-review

53 Scopus citations


Nonsteroidal antiinflammatory drugs (NSAIDs) have become an important adjunctive tool for surgeons performing routine and complicated cataract surgery. These medications have been found to reduce pain, prevent intraoperative miosis, modulate postoperative inflammation, and reduce the incidence of cystoid macular edema (CME). Whether used alone, synergistically with steroids, or for specific high-risk eyes prone to the development of CME, the effectiveness of these medications is compelling. This review describes the potential preoperative, intraoperative, and postoperative uses of NSAIDs, including the potency, indications and treatment paradigms and adverse effects and contraindications. A thorough understanding of these issues will help surgeons maximize the therapeutic benefits of these agents and improve surgical outcomes. Financial Disclosure Proprietary or commercial disclosures are listed after the references.

Original languageEnglish (US)
Pages (from-to)1368-1379
Number of pages12
JournalJournal of cataract and refractive surgery
Issue number9
StatePublished - Sep 1 2016

ASJC Scopus subject areas

  • Surgery
  • Ophthalmology
  • Sensory Systems


Dive into the research topics of 'Cataract surgery and nonsteroidal antiinflammatory drugs'. Together they form a unique fingerprint.

Cite this